Goldline Pharmaceutical Stock Performance

as on June 17, 2026 at 9:31 pm IST

Day's Low
Day's High
₹42.80
Day's Price Range
₹44.60
₹43.25
1.04%
Downside
3.12%
Upside
52 Week's Low
52 Week's High
₹41.76
52-Week Price Range
₹60.00
₹43.25
3.45%
Downside
38.73%
Upside

Goldline Pharmaceutical share price movements today

Previous Close: ₹44.65
Open: ₹44.60
Volume: 1.95L
Upper Circuit: ₹53.58
Lower Circuit: ₹35.72
Day's Low - High: ₹42.80 - ₹44.60
52 Week Low - High: ₹41.76 - ₹60.00

Goldline Pharmaceutical Historical Returns

1 Month Return: -24.17 %
3 Month Return: -24.17 %
1 Year Return: -24.17 %
3 Year Return: -24.17 %
5 Year Return: -24.17 %

Goldline Pharmaceutical Fundamentals

as on June 17, 2026 at 4:01 pm IST

Market Cap

₹829.58 Cr

Return on Equity (ROE)

9.83

PE Ratio (TTM)

-10.14

Return on capital employed (ROCE)

13.33

Beta (LTM)

1.39

P/B Ratio

2.4

Dividend Yield

0.28

PEG Ratio

2.39

Quarterly Earnings Growth YOY

EPS (TTM)

1.84

Book Value

Goldline Pharmaceutical Technical Analysis

Track how Goldline Pharmaceutical technical analysis has moved over time to understand its trends.

1 min

5 min

15 min

30 min

1 day

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12

Bullish2

Neutral1

Oscillators

Name	Value	Action
MACD level (12,26)	-0.11	Bearish
CCI (20)	-71.19	Neutral
RSI (14)	0.02	Bullish
Momentum (10)	0	Bullish
ADI (14)	95.24	Bearish
Ultimate Oscillator (7,14,28)	10.25	Bearish

Moving Averages

Name	Value	Action
SMA (20)	43.18	Bearish
EMA (20)	43.13	Bearish
VWMA (20)	43.09	Bearish
SMA (50)	43.31	Bearish
EMA (50)	43.28	Bearish
SMA (200)	43.59	Bearish
EMA (200)	43.52	Bearish
KAMA (200)	43	Bearish
DEMA (200)	43.33	Bearish

Goldline Pharmaceutical Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Goldline Pharmaceutical with its industry peers.

Company	Analyst View	Market Cap(in ₹ Cr)	5 Year CAGR	Debt to Asset Ratio	Net Profit(in ₹ Cr)	Yearly Revenue(in ₹ Cr)
Sigachi Industries Ltd	NA	829.58	-12.75%	0.60	70	488
Makers Laboratories Ltd	NA	87.74	-4.87%	0.71	10	120
Zenith Health Care Ltd	NA	16.77	-14.43%	0.00	NA	11
Caplin Point Laboratories Ltd	BUY	17,747.97	51.49%	0.51	541	1,937
Bajaj Healthcare Ltd	NA	1,007.19	-3.51%	0.00	39	542

See all

Goldline Pharmaceutical Ltd Quarterly Profit & Loss

Figures in Rupees Crores

	Dec 2025	Mar 2026
Sales	7.51	9.79
Total Income	7.52	9.79
Expenses	5.99	7.01
Operating Profit	1.52	2.78
Operating Profit Margin %	20.24%	28.4%
Profit Before Interest, Tax and Depreciation	1.52	2.78
Interest	0.3	0.35
Depreciation	0.06	0.06
Profit Before Tax	1.16	2.37
Tax Paid	0.29	0.48
Profit After Tax	0.87	1.89
Total Net profit including share of profit / Loss from associate company	0.87	1.89
EPS	1	2.18
Actual EPS	1	2.18
Adjusted EPS	1	2.18

Goldline Pharmaceutical Ltd Annual Profit & Loss

Figures in Rupees Crores

	Mar 2024	Mar 2025	Mar 2026
Sales	23.57	28.06	31.2
Total Income	23.57	28.06	31.2
Expenses	19.26	22.22	24.26
Operating Profit	4.31	5.84	6.94
Operating Profit Margin %	18.29%	20.81%	22.24%
Profit Before Interest, Tax and Depreciation	4.3	5.83	6.94
Interest	1.61	1.72	1.31
Depreciation	0.16	0.25	0.24
Profit Before Tax	2.53	3.86	5.39
Tax Paid	0.72	1.02	1.26
Profit After Tax	1.81	2.83	4.12
Total Net profit including share of profit / Loss from associate company	1.81	2.83	4.12
EPS	3.01	4.11	5.97
Actual EPS	3.01	4.11	5.97
Adjusted EPS	3.01	4.11	5.97
Diluted EPS	3.01	4.11	5.97

Goldline Pharmaceutical Ltd Cash Flow

Figures in Rupees Crores

	Mar 2023	Mar 2024	Mar 2025
Net Cash from Operating Activities	2.39	2.92	2.32
Cash Flow from Investing Activities	-1.04	-1.11	0.16
Cash Flow from Financing Activities	-1.44	-1.08	-2.03
Net Cash Flow	-0.09	0.74	0.45

Goldline Pharmaceutical Stock Shareholding Pattern

Numbers in percentages

	Sep 2025	May 2026
Promoters	79.71%	57.29%
DII	0%	7.81%
FII	0%	5.16%
Public	0%	29.74%
Total Outstanding Shares	69,00,000	96,00,000
Total Shareholders	20	271

Indices Featuring Goldline Pharmaceutical Stock

Check stock indices that include Goldline Pharmaceutical.

BSE SME IPO

₹95,744.19

0.15 (▲144.15%)

Insights on Goldline Pharmaceutical Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 0.00% to 29.74% in May 2026 quarter
POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 5.16% in May 2026 quarter
NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 79.71% to 57.29% in May 2026 quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, Goldline Pharmaceutical stock has moved down by -8.8%

About Goldline Pharmaceutical Ltd

Goldline Pharmaceutical Limited was originally incorporated on August 2 2004 as a private limited Company in the name of Goldline Pharmaceutical Private Limited with the Registrar of Companies Mumbai. Subsequently Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited w.e.f. September 23 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma Goldline Cardinal Goldline Aayushman Goldline InLife and Goldline Valiente. The pharmaceutical products marketed under the Goldline brand are not manufactured by Company. Instead they enter into contractual arrangements with thirdparty manufacturers who produce the products based on market research demand analysis and specifications. Presently Company maintain contractual arrangements with 15 manufacturers and 7 distributors ensuring a stable supply chain and consistent market presence.Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd Activista Healthcare Pvt Ltd Company manage trading and supply chain operations thereby ensuring reliable procurement seamless distribution and logistical efficiency.Company is planning the Initial Public Offer of 3000000 Equity Shares having the face value of Rs 10 each through Fresh Issue..

Revenue: ₹9.79Cr as on March 2026 (Q4 FY26)
Net Profit: ₹1.89Cr as on March 2026 (Q4 FY26)
Chairperson Name: AMOL LAXMIKANT MUJUMDAR

Organisation	Goldline Pharmaceutical Ltd
Industry	Pharmaceuticals
CEO	AMOL LAXMIKANT MUJUMDAR
E-voting on shares	Click here to vote

FAQs

What is Goldline Pharmaceutical share price today?

Goldline Pharmaceutical share price today stands at ₹43.25 as on June 17, 2026 at 4:01 pm IST at the close of the market. Goldline Pharmaceutical share today touched a day high of ₹44.6 and a low of ₹42.8.

What is the 52 week high and 52 week low range for Goldline Pharmaceutical share?

Goldline Pharmaceutical touched a 52 week high of ₹60 and a 52 week low of ₹41.76. Goldline Pharmaceutical share price today i.e. June 17, 2026 at 4:01 pm IST is closed at ₹43.25, which is -27.92% down from its 52 week high and 3.57% up from its 52 week low.

What is Goldline Pharmaceutical's market capitalisation today?

Goldline Pharmaceutical market capitalisation is ₹41.33 Cr as on June 17, 2026 at 4:01 pm IST.

How to buy Goldline Pharmaceutical shares?

To buy Goldline Pharmaceutical shares, you need to follow these steps:

Open a Demat account and Trading account on INDmoney
Fund your Trading account
Search for 544759 or Goldline Pharmaceutical Ltd on the INDmoney app to check live prices of the stock
Click on Buy or SIP to place an order to invest in Goldline Pharmaceutical shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Goldline Pharmaceutical trading volume today?

Goldline Pharmaceutical trading volume is 1.95L as on June 17, 2026 at 4:01 pm IST. This means that 1.95L shares of Goldline Pharmaceutical were bought and sold on the stock market during today's trading session.